COVID-19 and mitochondrial disease

Updated and current as at 19 March 2020

COVID-19 is a highly contagious disease transmitted by a type of coronavirus.

COVID-19 appears to cause a fever, dry cough and in some instances a subsequent severe lung inflammation and respiratory failure. Based on the limited information currently available, most of the reported fatalities have been in older people with pre-existing cardiovascular disease, diabetes and respiratory conditions.

It would be reasonable, therefore, to assume that adults or children with mito with pre-existing medical conditions could be at increased risk of developing more severe symptoms, but the vast majority would still have only a mild illness.

There are no specific vaccines or treatments available at the moment, so the advice for adults and children with mito is to familiarise yourself with information about COVID-19 and closely monitor developments via the Australian Government Department of Health Coronavirus Health Alert website.

More information on COVID-19 is available via the Coronavirus Health Information Line on 1800 020 080.  The line operates 24 hours a day, seven days a week.

Specific medical questions should be directed to your healthcare professional.

We are here to help. Please contact the Mito Foundation Helpline by calling 1300 977 180 or send us a request for support.

This statement has been adapted from the Lily Foundation’s statement with thanks and has been reviewed and approved by the medical members of the Mito Foundation Scientific & Medical Advisory Panel.